Showing results (1-10 of 2,593) with videos related to
Sort By:
Pageof 260
Current Oncology (Toronto, Ont.)|June 23, 2016
Approach to biomarker testing: perspectives from various specialtiesM R Sung, P M Ellis, S Verma, et al.Current Oncology (Toronto, Ont.)|July 13, 2012
Treatment paradigms for patients with metastatic non-small-cell lung cancer: first-, second-, and third-lineN B LeighlCurrent Oncology (Toronto, Ont.)|November 11, 2020
Diagnostic patterns of non-small-cell lung cancer at Princess Margaret Cancer CentreM Nadjafi, M R Sung, G D C Santos, et al.Current Oncology (Toronto, Ont.)|June 19, 2018
Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trialsG M O'Kane, T A Barnes, N B LeighlCurrent Oncology (Toronto, Ont.)|July 13, 2012
Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRASM D Vincent, M S Kuruvilla, N B Leighl, et al.British Journal of Cancer|January 20, 2011
Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on studyN B Leighl, J Bennouna, J Yi, et al.Current Oncology (Toronto, Ont.)|April 25, 2015
Management of egfr tki-induced dermatologic adverse eventsB Melosky, N B Leighl, J Rothenstein, et al.Current Oncology (Toronto, Ont.)|July 13, 2012
The importance of multidisciplinary team management of patients with non-small-cell lung cancerP M EllisEquine Veterinary Journal|January 1, 1975
The indirect measurement of arterial blood pressure in the horseP M EllisAnnals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Attitudes towards and participation in randomised clinical trials in oncology: a review of the literatureP M EllisPageof 260